本页面由Tiger Trade Technology Pte. Ltd.提供服务

Compass Therapeutics, Inc.

0.9375
-0.0555-5.59%
盘前:0.96370.0262+2.79%05:01 EDT
成交量:443.64万
成交额:416.22万
市值:1.69亿
市盈率:-2.32
高:0.9900
开:0.9900
低:0.9202
收:0.9930
52周最高:6.88
52周最低:0.8294
股本:1.80亿
流通股本:1.32亿
量比:0.61
换手率:3.36%
股息:- -
股息率:- -
每股收益(TTM):-0.4039
每股收益(LYR):-0.4216
净资产收益率:-56.66%
总资产收益率:-33.03%
市净率:1.02
市盈率(LYR):-2.22

数据加载中...

2021/04/30

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]
2021/04/19

重要事件披露

8-K - Current report
2021/03/05

年度报告

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2021/01/14

员工持股计划

S-8 - Securities to be offered to employees in employee benefit plans
2020/12/17

重要事件披露

8-K - Current report
2020/11/09

[修订]招股说明书

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933
2020/11/09

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]
2020/10/19

招股说明书

S-1 - General form for registration of securities under the Securities Act of 1933
2020/09/23

SEC问询函

CORRESP [Cover] - Correspondence
2020/09/18

[修订]招股说明书

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933
2020/09/15

重要事件披露

8-K - Current report
2020/08/13

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]
2020/08/11

招股说明书

S-1 - General form for registration of securities under the Securities Act of 1933
2020/08/10

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2020/07/31

重要事件披露

8-K/A [Amend] - Current report
2020/07/31

SEC问询函

CORRESP [Cover] - Correspondence
2020/06/29

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2020/06/29

超过5%披露

SC 13D - General statement of acquisition of beneficial ownership
2020/06/29

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2020/06/26

超过5%披露

SC 13D - General statement of acquisition of beneficial ownership